An independent resource

About

Steady Lantern 69 is built for adults who want a calmer, clearer way to understand emerging psychedelic therapies without overstating what research can support.

Our work is guided by plain language, evidence awareness, risk transparency, and respectful nuance.

Hands held thoughtfully in a calm setting, reflecting careful consideration of complex health information
Quiet natural landscape supporting a measured and reflective approach to information

Why this exists

Make room for careful understanding.

Myco Haven is an independent resource on psilocybin, ibogaine, evidence, safety, and policy. It exists to help people understand meaningful differences without making medical promises or treating uncertainty as a flaw to be hidden.

The material is organized so readers can move from a grounded comparison of psilocybin and ibogaine toward the questions that shape responsible interpretation: what is established, what remains preliminary, and what deserves professional discussion outside this resource.

We distinguish between research findings, regulatory information, and practical claims. That distinction matters because study registration and reporting have formal public records, including the ClinicalTrials.gov study registry, but a listed study is not the same as a proven outcome.

Our editorial approach

Evidence first, certainty second.

Steady Lantern 69 starts with primary literature, trial registries, public-health guidance, official policy materials, and clearly identified reference sources. We aim to describe what a source says, its limits, and the context readers need before drawing conclusions.

When a term needs a stable baseline, we may point to established references such as the overview of evidence-based medicine. These references support orientation; they do not replace close reading of the underlying evidence.

Our site guidance and reading pathways are designed to help readers find material by question rather than by hype. The tone stays plainspoken because complex topics should not require opaque language to be treated seriously.

  • Independence over promotion
  • Plain language over jargon
  • Evidence awareness over certainty
  • Risk transparency over reassurance
  • Respectful nuance over simple answers

What we cover

Questions arranged for context.

Our materials are organized around evidence, safety, policy, mechanisms, effects, and the practical questions adults bring to a comparison. They are intended to support informed reading, not to direct a medical decision or recommend a provider, program, or pathway.

In that spirit, we examine how outside resources frame specific subjects without endorsing them. Readers may encounter information about ibogaine and MMA discussions, martial arts-related ibogaine material, and reported ibogaine treatment costs in Mexico as examples of the broader online information environment.

What is being claimed?

We identify whether a statement refers to research, regulation, an individual account, or a commercial claim.

What supports it?

We look for accessible primary sources, official material, and the limits built into each type of evidence.

What remains uncertain?

We retain ambiguity where it belongs instead of converting incomplete evidence into a tidy answer.

Who this is for

A reference point, not a destination for care.

Steady Lantern 69 is for adults seeking a grounded comparison of psilocybin and ibogaine research, risks, and evolving access. It is not built to decide what is right for any individual, and it cannot assess health history, medication interactions, legal circumstances, or personal safety.

We also recognize that access language can blur the line between information and marketing. For that reason, references to Canada-focused ibogaine information, ibogaine stock-related material, and treatment facility claims in Mexico are approached as material to assess, not as recommendations.

When legal or policy questions arise, readers should use official sources appropriate to their own location. For example, the DEA’s drug scheduling information illustrates why regulatory context should be checked directly rather than inferred from a general discussion.

Independent by design

Information with its boundaries intact.

We do not act as a clinic, medical provider, licensed treatment center, or legal authority. Our purpose is to offer a careful place to orient yourself, evaluate claims, and recognize when a question belongs with qualified local professionals.

If you want to understand the resource’s scope before exploring it, the contact page explains the available route for reaching the brand without turning this site into a care service.

Myco Haven is an independent information resource, not a clinic, medical provider, or licensed treatment center. Its content is not medical or legal advice.